Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Polymerase Chain Reaction Technology
- Point of Care PCR Systems and Assays
Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Market Opportunities
- Market Restraints
- Market Challenges
Chapter 4 Emerging Technologies and Developments
- Overview
- Instrument-Free PCR Tests
- Five-Minute Point-of-Care Testing
- Smartphone Enabled PCR System
- Patents
- Selected Patents
Chapter 5 Global Market for PCR POC Diagnostics
- Segmentation Breakdown
- Market Breakdown by Product Type
- Market Breakdown by Analyte
- PCR POC Analyzers by Analyte
- PCR POC Consumables by Analyte
- Market Breakdown by Application
- Infectious Diseases
- STIs
- Geographic Breakdown
- Market Breakdown by Region
- North America
- Latin America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Industry Scenario
- Company Shares
- Competitive Landscape Among Companies
- Competitive Landscape in POC PCR Analyzers
- Competitive Landscape in POC PCR Consumables
Chapter 7 Sustainability in the Market for Polymerase Chain Reaction for Point of Care Diagnostics: An ESG Perspective
- Introduction to ESG
- Sustainability in Polymerase Chain Reaction for Point-of-Care Diagnostic Industry: An ESG Perspective
- Key ESG Issues
- ESG Performance Analysis
- Concluding Remarks
List of Tables
Summary Table: Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, Through 2029
Table 1: Global HIV Infections, 2022
Table 2: People Living with HIV, by Region, 2022
Table 3: Global Incidence of All Cancers, by Region, 2022-2050
Table 4: Global Incidence of Leukemia, by Region, 2022-2050
Table 5: Global Incidence of Hodgkin Lymphoma, by Region, 2022-2050
Table 6: Global Incidence of Non-Hodgkin Lymphoma, by Region, 2022-2050
Table 7: Global Incidence of Multiple Myeloma, by Region, 2022-2050
Table 8: Selected Patents on PCR POC Technology, 2015-Present
Table 9: Global Market for PCR POC Diagnostics, Through 2029
Table 10: Global Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 11: Global Market for PCR POC Analyzers, by Analyte, Through 2029
Table 12: Global Market for Single Analyte PCR POC Analyzers, by Region, Through 2029
Table 13: Global Market for Multi-Analyte PCR POC Analyzers , by Region, Through 2029
Table 14: Global Market for PCR POC Consumables, by Analyte, Through 2029
Table 15: Global Market for Single Analyte PCR POC Consumables, by Region, Through 2029
Table 16: Global Market for Multi-Analyte PCR POC Consumables, by Region, Through 2029
Table 17: Global Market for PCR for POC Diagnostics, by Application, Through 2029
Table 18: Global Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 19: Global Market for PCR POC Diagnostics in Infectious Diseases, by Region, Through 2029
Table 20: North American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 21: North American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 22: Latin American Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 23: Latin American Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 24: European Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 25: European Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 26: Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 27: Asia-Pacific Market for PCR POC Diagnostics in Infectious Diseases, by Country, Through 2029
Table 28: RoW Market for PCR POC Diagnostics in Infectious Diseases, Through 2029
Table 29: Global Market for PCR POC Diagnostics in STIs, Through 2029
Table 30: Global Market for PCR POC Diagnostics in STIs, by Region, Through 2029
Table 31: North American Market for PCR POC Diagnostics in STIs, Through 2029
Table 32: North American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 33: Latin American Market for PCR POC Diagnostics in STIs, Through 2029
Table 34: Latin American Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 35: European Market for PCR POC Diagnostics in STIs, Through 2029
Table 36: European Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 37: Asia-Pacific Market for PCR POC Diagnostics in STIs, Through 2029
Table 38: Asia-Pacific Market for PCR POC Diagnostics in STIs, by Country, Through 2029
Table 39: RoW Market for PCR POC Diagnostics in STIs, Through 2029
Table 40: Global Market for PCR for POC Diagnostics, by Region, Through 2029
Table 41: North American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 42: North American Market for PCR POC Diagnostics, by Country, Through 2029
Table 43: Latin American Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 44: Latin American Market for PCR POC Diagnostics, by Country, Through 2029
Table 45: European Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 46: European Market for PCR POC Diagnostics, by Country, Through 2029
Table 47: Asia-Pacific Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 48: Asia-Pacific Market for PCR POC Diagnostics, by Country, Through 2029
Table 49: RoW Market for PCR POC Diagnostics, by Product Type, Through 2029
Table 50: ESG: Environmental Overview
Table 51: ESG: Social Overview
Table 52: ESG: Governance Overview
Table 53: ESG Rankings for Polymerase Chain Reaction Point-of-Care Diagnostics Companies, 2023*
Table 54: Acronyms Used in This Report
Table 55: Abbott: Company Snapshot
Table 56: Abbott: Financial Performance, 2022 and 2023
Table 57: Abbott: Product Portfolio
Table 58: Abbott: News/Key Developments, 2022
Table 59: Credo Diagnostics Biomedical Pte. Ltd.: Company Snapshot
Table 60: Credo Diagnostics Biomedical Pte. Ltd.: Product Portfolio
Table 61: Credo Diagnostics Biomedical Pte. Ltd.: News/Key Developments, 2022
Table 62: Danaher Corp.: Company Snapshot
Table 63: Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 64: Danaher Corp.: Product Portfolio
Table 65: Danaher Corp.: News/Key Developments, 2023 and 2024
Table 66: F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 67: F. Hoffmann-La Roche Ltd.: Financial Performance, 2022 and 2023
Table 68: F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 69: QIAGEN: Company Snapshot
Table 70: QIAGEN: Financial Performance, FY 2022 and 2023
Table 71: QIAGEN: Product Portfolio
Table 72: QIAGEN: News/Key Developments, 2022
Table 73: Quantumdx Group Ltd.: Company Snapshot
Table 74: Quantumdx Group Ltd.: Product Portfolio
Table 75: Thermo Fisher Scientific Inc.: Company Snapshot
Table 76: Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 77: Thermo Fisher Scientific Inc.: Product Portfolio
Table 78: Thermo Fisher Scientific Inc.: News/Key Developments, 2021
Table 79: Visby Medical Inc.: Company Snapshot
Table 80: Visby Medical Inc.: Product Portfolio
Table 81: Visby Medical Inc.: News/Key Developments, 2023
List of Figures
Summary Figure A: Global Market for Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2021-2029
Summary Figure B: Global Market Shares of Polymerase Chain Reaction for Point-of-Care Diagnostics, by Product Type, 2023
Figure 1: Polymerase Chain Reaction for Point of Care Diagnostics: Market Dynamics
Figure 2: Emerging Trends and Technologies in PCR for POC Diagnostics
Figure 3: Global Market Shares of PCR POC Diagnostics, by Company, 2023
Figure 4: Global Market Shares of POC PCR Analyzers, by Company, 2023
Figure 5: Global Market Shares of POC PCR Consumables, by Company, 2023
Figure 6: ESG Pillars
Figure 7: Advantages of ESG for Companies
Figure 8: Share of ESG Penetration in Polymerase Chain Reaction POC Diagnostics Market, 2023
Figure 9: Abbott: Revenue Share, by Business Unit, 2023
Figure 10: Abbott: Revenue Share, by Country/Region, 2023
Figure 11: Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 12: Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 13: F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 14: F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 15: QIAGEN: Revenue Share, by Business Unit, FY 2023
Figure 16: QIAGEN: Revenue Share, by Country/Region, FY 2023
Figure 17: Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023
Figure 18: Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023
